[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100640200":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":50,"collaborators":24,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":24,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":24,"enrollmentInfo":63,"targetDuration":24,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":24,"overallStatus":36,"whyStopped":24,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group S","EXPERIMENTAL","Patients will receive superior hypogastric plexus block (SHPB) using 20ml of bupivacaine 0.25%+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.",[13],"Other: Superior hypogastric plexus block + Transverse abdominis plane",{"label":15,"type":16,"description":17,"interventionNames":18},"Group C","ACTIVE_COMPARATOR","Patients will receive superior hypogastric plexus block (SHPB) using 20ml of saline 0.9% (sham)+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.",[19],"Other: Superior hypogastric plexus block",[21,25],{"type":6,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"Superior hypogastric plexus block + Transverse abdominis plane",[9],null,{"type":6,"name":26,"description":17,"armGroupLabels":27,"otherNames":24},"Superior hypogastric plexus block",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Mohammed S Elsharkawy, MD","CONTACT","00201148207870","mselsharkawy@med.tanta.edu.eg",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Tanta","El-Gharbia","31527","Egypt","EG",{"type":43,"coordinates":44},"Point",[45,46],31.00192,30.78847,{"lat":46,"lon":45},[49],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Mohammed Said ElSharkawy","Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.","100640200","combination-of-superior-hypogastric-plexus-block-and-transversus-abdominis-plane-block-in-abdominal-hysterectomies-100640200",false,"NCT07606781","Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies","Analgesic Effect of Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Age ≥ 18 years.\n* American Society of Anesthesiology (ASA) physical status I-II.\n* Undergoing abdominal hysterectomies under general anesthesia (GA).\n\nExclusion Criteria:\n\n* History of allergies to local anesthetics.\n* Body mass index (BMI) \\>35 kg\u002Fm2.\n* Opioid dependency.\n* Cognitive impairment.\n* Bleeding or coagulation disorders.\n* Psychiatric and neurological disorder.\n* Local infection at the site of injection.\n* Severe heart, lung, liver, and renal dysfunction.","FEMALE","18 Years",{"count":64,"type":65},44,"ESTIMATED","INTERVENTIONAL",[68],"NA","This study aims to evaluate the analgesic effect of superior hypogastric plexus block combined with transversus abdominis plane block in abdominal hysterectomies.",[71,72,73],"Superior Hypogastric Plexus Block","Transversus Abdominis Plane Block","Abdominal Hysterectomies","2026-05-23",{"date":76,"type":77},"2026-05-27","ACTUAL",{"date":74,"type":77},{"date":80,"type":65},"2026-10-01",{"name":5,"class":6},1]